Tara Lin
0000-0002-0242-6449
3 papers found
Refreshing results…
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial
Missing publications? Search for publications with a matching author name.